Cargando…

Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis

BACKGROUND: Epidemiological studies have shown that patients with type 2 diabetes mellitus (T2DM) are at a higher risk of secondary tumors. However, no consensus has been made about whether T2DM can increase the risk of multiple myeloma (MM). METHODS: We searched the databases of PubMed, Cochrane Li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chenlu, Sha, Yuou, Liu, Haiyan, Guo, Dan, Jiang, Yijing, Hong, Lemin, Shi, Lili, Huang, Hongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798954/ https://www.ncbi.nlm.nih.gov/pubmed/35117645 http://dx.doi.org/10.21037/tcr.2020.03.36

Ejemplares similares

ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L
por: Liu, Haiyan, et al.
Publicado: (2020)

The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis
por: Jiang, Yuwen, et al.
Publicado: (2022)

lncRNA transcription factor 7 is related to deteriorating clinical features and poor prognosis in multiple myeloma, and its knockdown suppresses disease progression by regulating the miR-203-mediated Jagged1-Notch1 signaling pathway
por: Liu, Haiyan, et al.
Publicado: (2021)

Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Jiang, Yijing, et al.
Publicado: (2020)

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
por: Liu, Haiyan, et al.
Publicado: (2019)

PB2080: LOW DUP1 EXPRESSION PREDICTS POOR PROGNOSIS IN MULTIPLE MYELOMA
por: Lu, Jinfeng, et al.
Publicado: (2023)

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy
por: Liu, Haiyan, et al.
Publicado: (2019)

IL-17A Increases Multiple Myeloma Cell Viability by Positively Regulating Syk Expression
por: Wang, Shunye, et al.
Publicado: (2019)

Myeloma and diabetes mellitus
por: Yasri, Sora, et al.
Publicado: (2014)

Does depression increase the risk of gestational diabetes mellitus? A systematic review and meta-analysis
por: Zhang, Chuanjiang, et al.
Publicado: (2023)

Does Diabetes Mellitus Increase the Risk of Avascular Osteonecrosis? A Systematic Review and Meta-Analysis
por: Konarski, Wojciech, et al.
Publicado: (2022)

Multiple Myeloma and Diabetes
por: Issa, Zeinab A., et al.
Publicado: (2011)

CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients
por: Ke, Mengying, et al.
Publicado: (2021)

Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p
por: Yang, Xi, et al.
Publicado: (2020)

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
por: Chen, Runzhe, et al.
Publicado: (2017)

Does Type 2 Diabetes Mellitus Increase Postoperative Complications in Patients Submitted to Cardiovascular Surgeries?
por: Padovani, Cauê, et al.
Publicado: (2020)

Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma
por: Fujiya, Atsushi, et al.
Publicado: (2010)

The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2022)

Prevalence of type 2 diabetes mellitus among inland residents in China (2000–2014): A meta‐analysis
por: Yang, Lili, et al.
Publicado: (2016)

The Acidic Microenvironment: Is It a Phenotype of All Cancers? A Focus on Multiple Myeloma and Some Analogies with Diabetes Mellitus
por: Fais, Stefano, et al.
Publicado: (2020)

Increased Risk of Cutaneous Diseases in Multiple Myeloma Patients
por: Buntinx-Krieg, Talayesa, et al.
Publicado: (2020)

Venous thromboembolism in multiple myeloma is associated with increased mortality
por: Schoen, Martin W., et al.
Publicado: (2020)

Smoldering Multiple Myeloma
por: Gao, Minjie, et al.
Publicado: (2015)

Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?
por: Gahrton, Gösta, et al.
Publicado: (2020)

Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
por: Zhao, Lili, et al.
Publicado: (2023)

Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury
por: Hudier, Laurent, et al.
Publicado: (2018)

Increased frequency of Mediterranean fever gene variants in multiple myeloma
por: CELIK, SERKAN, et al.
Publicado: (2014)

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
por: Zaal, Esther A., et al.
Publicado: (2017)

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma
por: Ruiz-Heredia, Yanira, et al.
Publicado: (2021)

Does benzene cause multiple myeloma? An analysis of the published case-control literature.
por: Bezabeh, S, et al.
Publicado: (1996)

Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma
por: Li, Panpan, et al.
Publicado: (2023)

Does type 2 diabetes mellitus promote intervertebral disc degeneration?
por: Fabiane, Stella Maris, et al.
Publicado: (2016)

Does COVID-19 predispose patients to type 1 diabetes mellitus?
por: Ata, Aysun, et al.
Publicado: (2021)

Multiple myeloma
por: Collins, Conor D
Publicado: (2004)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

Multiple Myeloma
por: Mandelli, F
Publicado: (1995)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Crawford, A. Muir
Publicado: (1933)

Multiple Myeloma
por: Parker, D., et al.
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_84b49r96kfcnc9s3s2ej5juc82